$2500 | Single User
$5000 | Site License
$7500 | Global License

Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018
[Report Updated: 25-10-2018]

Published by Global Data: 25 Oct 2018 | 227671 | In Stock
Related Topics: Clinical Trials

Introduction

Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018" provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018 [Report Updated: 25-10-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Five Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Countries Contributing to Clinical Trials in Middle East and Africa 14

    Top Five Countries Contributing to Clinical Trials in Central and South America 15

    Clinical Trials by G7 Countries: Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials 16

    Clinical Trials by Phase in G7 Countries 18

    Clinical Trials in G7 Countries by Trial Status 19

    Clinical Trials by E7 Countries: Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials 20

    Clinical Trials by Phase in E7 Countries 22

    Clinical Trials in E7 Countries by Trial Status 23

    Clinical Trials by Phase 24

    In Progress Trials by Phase 25

    Clinical Trials by Trial Status 26

    Clinical Trials by End Point Status 28

    Subjects Recruited Over a Period of Time 29

    Clinical Trials by Sponsor Type 30

    Prominent Sponsors 31

    Top Companies Participating in Diabetic Foot Infection (DFI) Therapeutics Clinical Trials 33

    Prominent Drugs 35

    Clinical Trial Profile Snapshots 36

    Appendix 74

    Abbreviations 74

    Definitions 74

    Research Methodology 75

    Secondary Research 75

    About GlobalData 75

    Contact Us 76

    Source 76

List Of Tables
in Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018 [Report Updated: 25-10-2018]

List of Tables

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Region, 2018* 7

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15

Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 17

Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19

Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 21

Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22

Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Phase, 2018* 24

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29

Diabetic Foot Infection (DFI) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35

List Of Figures, Charts and Diagrams
in Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018 [Report Updated: 25-10-2018]

List of Figures

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15

Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2018* 16

Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Diabetic Foot Infection (DFI) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19

Proportion of Diabetic Foot Infection (DFI) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2018* 20

Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22

Diabetic Foot Infection (DFI) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25

Diabetic Foot Infection (DFI) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29

Diabetic Foot Infection (DFI) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33

Diabetic Foot Infection (DFI) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35

GlobalData Methodology 75

Additional Details

Publisher

Global Data

Publisher Information

Reference

227671 | GDHC5393CTIDB

Number of Pages

76

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2016
Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial repor...
31 May 2016 by Global Data USD $2,500 More Info
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tr...
31 May 2016 by Global Data USD $2,500 More Info
Diabetic Macular Edema Global Clinical Trials Review, H1, 2016
Diabetic Macular Edema Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial rep...
31 May 2016 by Global Data USD $2,500 More Info
Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016
Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial repo...
31 May 2016 by Global Data USD $2,500 More Info
Diabetic Nephropathy Global Clinical Trials Review, H1, 2016
Diabetic Nephropathy Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial repor...
31 May 2016 by Global Data USD $2,500 More Info
Diabetic Neuropathy Global Clinical Trials Review, H1, 2016
Diabetic Neuropathy Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report...
31 May 2016 by Global Data USD $2,500 More Info
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial rep...
19 May 2016 by Global Data USD $2,500 More Info
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial rep...
11 Mar 2016 by Global Data USD $2,500 More Info
Diabetic Complications Global Clinical Trials Review, H2, 2015
Diabetic Complications Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial rep...
23 Dec 2015 by Global Data USD $2,500 More Info
Physician Views: What commercial impact for Eylea from the Protocol T study in diabetic macular oedema?
Scope It seems that controversy over the use of off-label Avastin as a much cheaper alternative to L...
19 Apr 2015 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018 [Report Updated: 25-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...